Cover Image

Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach

Saved in:

Bibliographic Details
Main Authors:	Kailyn Valido, BS (Author), Vandan Patel, DO (Author), Michael J. Murphy, BS (Author), Muhammad H. Junejo, MD (Author), Devisha K. Patel, DO (Author), Alana Deutsch, MD (Author), Noel Turner, MD (Author), Theodore D. Zaki, MD (Author), Brett King, MD, PhD (Author), William Damsky, MD, PhD (Author), Caroline A. Nelson, MD (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Successful treatment of pityriasis rubra pilaris with brodalumab after nonresponse to IL-17A inhibition: A role for the innate cytokine IL-17C
by: Kailyn Valido, BS, et al.
Published: (2024)

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)

Treatment of lichen sclerosus and hypertrophic scars with dupilumab
by: Danielle M. Peterson, MD, et al.
Published: (2022)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
by: Jonathan J. Park, PhD, et al.
Published: (2023)

Did dupilumab unmask smoldering mycosis fungoides?
by: Michelle Toker, BS, et al.
Published: (2023)

Nonepisodic angioedema with eosinophilia with remarkably high blood eosinophil counts
by: Kenji Hara, MD, et al.
Published: (2022)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
by: Masako Yamamoto, MD, et al.
Published: (2022)

Modafinil-induced drug reaction with eosinophilia and systemic symptoms syndrome
by: Stacy Y. Kasitinon, MD, PhD, et al.
Published: (2022)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021)

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
by: Ronan Talty, BS, et al.
Published: (2022)

Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature
by: Gabriela Fonseca, BS, et al.
Published: (2024)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Minocycline induced drug rash with eosinophilia and systemic symptoms complicated by hemophagocytic lymphohistiocytosis
by: Raymond Zhao, BS, et al.
Published: (2023)

Resolution of dupilumab-associated alopecia areata with dosage modification
by: Maansi Kulkarni, BS, et al.
Published: (2022)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023)

Erythrodermic scabies in an immunocompetent patient
by: Ronan Talty, BS, et al.
Published: (2022)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022)

Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome
by: Xiaoman Du, MD, et al.
Published: (2022)

Keratosis lichenoides chronica successfully treated with isotretinoin and methotrexate
by: Alvin W. Li, BS, et al.
Published: (2017)

Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab
by: Aurélie Du-Thanh, MD, PhD, et al.
Published: (2021)

Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
by: Makoto Ito, MD, et al.
Published: (2020)

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Clinical manifestations of drug reaction with eosinophilia and systemic symptoms in pediatric patients
by: Suzanne Blackley, MS, et al.
Published: (2024)

A case of leukocytoclastic vasculitis in a patient on dupilumab
by: Michelle S. Bach, BS, et al.
Published: (2023)

Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD)
by: Jodie Raffi, BA, et al.
Published: (2019)

Hydroxychloroquine-Induced Toxic Myopathy Causing Diaphragmatic Weakness and Lung Collapse Requiring Prolonged Mechanical Ventilation
by: Julie Pillittere MD, et al.
Published: (2020)

De novo case of lichenoid eruption following dupilumab treatment
by: Tae-Eun Kim, MD, et al.
Published: (2021)

Pyoderma gangrenosum developing in a patient treated with dupilumab
by: Jessica Nasseh, MD, et al.
Published: (2022)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020)

Pemphigoid gestationis treated with dupilumab
by: Rita E. Chen, BA, et al.
Published: (2023)

Severe Prolonged Hypothyroidism
by: Yonatan Yeshayahu MD, MHA, et al.
Published: (2015)

Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021)

Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia
by: Gabriela Pabón-Cartagena, MD, et al.
Published: (2020)

Refractory eczematous dermatitis arising after allogeneic hematopoietic stem cell transplantation responsive to dupilumab
by: Jenny Lai, PhD, et al.
Published: (2024)

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib
by: Camille Pinard, MD, et al.
Published: (2017)

Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis
by: Bethany F. Wilken, MSc, et al.
Published: (2024)